98 related articles for article (PubMed ID: 8760186)
1. Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ.
Suzuki H; Noda Y; Gao XP; Séjourné F; Alkan-Onyuksel H; Paul S; Rubinstein I
Am J Physiol; 1996 Jul; 271(1 Pt 2):H282-7. PubMed ID: 8760186
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo.
Suzuki H; Noda Y; Paul S; Gao XP; Rubinstein I
Life Sci; 1995; 57(15):1451-7. PubMed ID: 7674836
[TBL] [Abstract][Full Text] [Related]
3. PGH(2)-TxA(2)-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension.
Suzuki H; Ikezaki H; Hong D; Rubinstein I
J Appl Physiol (1985); 2000 Jun; 88(6):1983-8. PubMed ID: 10846009
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo.
Séjourné F; Suzuki H; Alkan-Onyüksel H; Gao XP; Ikezaki H; Rubinstein I
Am J Physiol; 1997 Jul; 273(1 Pt 2):R287-92. PubMed ID: 9249562
[TBL] [Abstract][Full Text] [Related]
5. Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo.
Ikezaki H; Onyüksel H; Rubinstein I
Am J Physiol; 1998 Aug; 275(2):R588-95. PubMed ID: 9688697
[TBL] [Abstract][Full Text] [Related]
6. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch.
Ikezaki H; Paul S; Alkan-Onyüksel H; Patel M; Gao XP; Rubinstein I
Am J Physiol; 1998 Jul; 275(1):R56-62. PubMed ID: 9688960
[TBL] [Abstract][Full Text] [Related]
7. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo.
Rubinstein I; Ashok B; Tsueshita T; Onyüksel H
Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658
[TBL] [Abstract][Full Text] [Related]
8. Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.
Ikezaki H; Patel M; Onyüksel H; Akhter SR; Gao XP; Rubinstein I
Am J Physiol; 1999 May; 276(5):R1359-65. PubMed ID: 10233028
[TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase modulates VIP-induced vasodilation in hamster cheek pouch vessels in situ.
Suzuki H; Gao XP; Olopade CO; Rubinstein I
Am J Physiol; 1996 Aug; 271(2 Pt 2):R393-7. PubMed ID: 8770140
[TBL] [Abstract][Full Text] [Related]
10. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin.
Rubinstein I; Patel M; Ikezaki H; Dagar S; Onyüksel H
Peptides; 1999 Dec; 20(12):1497-501. PubMed ID: 10698126
[TBL] [Abstract][Full Text] [Related]
11. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation.
Tsueshita T; Onyükusel H; Sethi V; Gandhi S; Rubinstein I
Peptides; 2004 Jan; 25(1):65-9. PubMed ID: 15003357
[TBL] [Abstract][Full Text] [Related]
12. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I
Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters.
Rubinstein I; Ikezaki H; Onyüksel H
Int J Pharm; 2006 Jun; 316(1-2):144-7. PubMed ID: 16580160
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure.
Gao XP; Noda Y; Rubinstein I; Paul S
Life Sci; 1994; 54(15):PL247-52. PubMed ID: 8152324
[TBL] [Abstract][Full Text] [Related]
15. Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension.
Onyüksel H; Séjourné F; Suzuki H; Rubinstein I
Peptides; 2006 Sep; 27(9):2271-5. PubMed ID: 16621151
[TBL] [Abstract][Full Text] [Related]
16. Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo.
Gandhi S; Tsueshita T; Onyüksel H; Chandiwala R; Rubinstein I
Peptides; 2002 Aug; 23(8):1433-9. PubMed ID: 12182944
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase.
Mayhan WG; Sharpe GM
J Appl Physiol (1985); 1999 Apr; 86(4):1126-34. PubMed ID: 10194193
[TBL] [Abstract][Full Text] [Related]
18. A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.
Onyüksel H; Ikezaki H; Patel M; Gao XP; Rubinstein I
Pharm Res; 1999 Jan; 16(1):155-60. PubMed ID: 9950295
[TBL] [Abstract][Full Text] [Related]
19. Liposomal vasoactive intestinal peptide.
Sethi V; Onyüksel H; Rubinstein I
Methods Enzymol; 2005; 391():377-95. PubMed ID: 15721392
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors modulate agonist-induced vasodilation in the hamster cheek pouch.
Ikezaki H; Akhter SR; Hong D; Suzuki H; Gao XP; Rubinstein I
J Appl Physiol (1985); 2000 Mar; 88(3):857-62. PubMed ID: 10710379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
